ReviewNeuroprotection (Chichester, England)2025
Bibliometric analysis and core target identification of network pharmacology on neuroinflammation in central nervous system disorders: Trends, collaborations, and future directions.
Review in Neuroprotection (Chichester, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuroinflammation is increasingly recognized as a critical driver of central nervous system (CNS) disorders, and network pharmacology has emerged as a promising approach to elucidate its complex mechanisms and therapeutic strategies. This study provides a comprehensive bibliometric and scientometric analysis of publications over the past 13 years to characterize research trends, identify key contributors, and uncover core therapeutic targets in this field. Articles published between January 2012 and May 2024 were retrieved from the Web of Science Core Collection. Visualization and quantitative analyses were performed using CiteSpace (version 6.3.R1, Drexel University, PA, United States) and VOSviewer (version 1.6.20, Leiden University - CWTS, Netherlands) followed by network interaction analysis to identify central targets implicated in neuroinflammation. A total of 156 publications were analyzed, with the United States, China, and Germany leading global output. Beijing University of Chinese Medicine, Case Western Reserve University, and University System of Ohio were identified as the most influential institutions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.